Low-dose combination of blood pressure-lowering medicines

Affiliations

¹ Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, SE-182 88 Stockholm, Sweden; Department of Cardiology, Danderyd University Hospital Corporation, Stockholm, Sweden. Electronic address: thomas.kahan@sll.se.

Comment

Thomas Kahan. Lancet. 2021.

. 2021 Sep 18;398(10305):1022-1023.

doi: 10.1016/S0140-6736(21)01964-4. Epub 2021 Aug 30.

¹ Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, SE-182 88 Stockholm, Sweden; Department of Cardiology, Danderyd University Hospital Corporation, Stockholm, Sweden. Electronic address: thomas.kahan@sll.se.

No abstract available

Comment on

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
Chow CK, Atkins ER, Hillis GS, Nelson MR, Reid CM, Schlaich MP, Hay P, Rogers K, Billot L, Burke M, Chalmers J, Neal B, Patel A, Usherwood T, Webster R, Rodgers A; QUARTET Investigators. Chow CK, et al. Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469767 Clinical Trial.